Sign In
Buy EMBC
$3.13
+0.100 (+3.30%)
At Close: Jun 23, 2026
embecta Announces Quarterly Cash Dividend
06:00am, Thursday, 09'th May 2024
PARSIPPANY, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstandin
embecta to Participate in Investor Events
05:00pm, Wednesday, 01'st May 2024
PARSIPPANY, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced that managem
embecta to Report Fiscal Second Quarter 2024 Financial Results
05:00pm, Tuesday, 23'rd Apr 2024
PARSIPPANY, N.J., April 23, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference cal
embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes
06:00am, Wednesday, 06'th Mar 2024
PARSIPPANY, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced its sponso
Best Value Stocks to Buy for February 12th
05:51am, Monday, 12'th Feb 2024
XRX, EMBC and HMN made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 12, 2023.
Why Embecta Stock Is Tanking Today
11:43am, Friday, 09'th Feb 2024
Embecta beat Wall Street estimates with its fiscal 2024 Q1 revenue and earnings. The company's full-year outlook, though, came in below consensus estimates.
Embecta Corp. (EMBC) Surpasses Q1 Earnings and Revenue Estimates
08:46am, Friday, 09'th Feb 2024
Embecta Corp. (EMBC) came out with quarterly earnings of $0.61 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.96 per share a year ago.
Embecta Corp. Reports First Quarter Fiscal 2024 Financial Results
06:30am, Friday, 09'th Feb 2024
PARSIPPANY, N.J., Feb. 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three month
embecta Announces Quarterly Cash Dividend
06:00am, Friday, 09'th Feb 2024
PARSIPPANY, N.J., Feb. 09, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstandi
embecta to Participate in the 11th Annual BTIG MedTech Conference
05:00pm, Wednesday, 07'th Feb 2024
PARSIPPANY, N.J., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will host one-on-one investor meetings on Tuesday, February 13, 2024, at the
embecta to Report Fiscal First Quarter 2024 Financial Results
05:00pm, Wednesday, 24'th Jan 2024
PARSIPPANY, N.J., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call
embecta Announces FDA 510(k) Submission for Insulin Patch Pump
06:00am, Tuesday, 09'th Jan 2024
PARSIPPANY, N.J., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced that it has sub
Time to Buy These Intriguing Additions to Zacks Rank #1 (Strong Buy) List
03:47pm, Wednesday, 20'th Dec 2023
Several intriguing stocks were recently added to the Zacks Rank #1 (Strong Buy) list this week and shouldn't be overlooked as we round out what has been an exciting year for the stock market.
embecta to Participate at the 42nd Annual J.P. Morgan Healthcare Conference
05:00pm, Thursday, 14'th Dec 2023
PARSIPPANY, N.J., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco on Wed
No embecta-made syringes impacted by FDA safety communication
06:00am, Friday, 01'st Dec 2023
PARSIPPANY, N.J., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, today issued the following statement regarding the U.S. Food and Drug
